Ivermectin, a potential anticancer drug derived from an antiparasitic drug (2021)

Peer-Reviewed Study · Tang M, Hu X, Wang Y, Yao X, Zhang W, Yu C, Cheng F, Li J, Fang Q · January 2021

Tang M et al., 2021-01: A Chinese review of ivermectin's anticancer mechanisms and preclinical evidence.

Recently, ivermectin has been reported to inhibit the proliferation of several tumor cells by regulating multiple signaling pathways.

105207

Tang M et al., 2021-01: A Chinese review of ivermectin's anticancer mechanisms and preclinical evidence. Study type: review.